Core Scientific (CORZR) Cash from Investing Activities (2021 - 2026)

Core Scientific's Cash from Investing Activities history runs 6 years deep, the most recent figure standing at -$386.7 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 334.36% year-over-year to -$386.7 million; the TTM figure through Mar 2026 stood at -$1.0 billion (down 582.08% YoY), while the FY2025 annual figure was -$740.8 million, down 678.16% from the prior year.
• Cash from Investing Activities came in at -$386.7 million for Q1 2026 at Core Scientific, down from -$277.8 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $2.4 million in Q4 2023 to a low of -$386.7 million in Q1 2026.
• A 5-year average of -$106.8 million and a median of -$32.0 million in 2024 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities soared 101.69% in 2023 and tumbled 3656.53% in 2025, its largest moves.
• Core Scientific's Cash from Investing Activities stood at -$139.5 million in 2022, then jumped by 101.69% to $2.4 million in 2023, then slumped by 1320.25% to -$28.8 million in 2024, then slumped by 864.54% to -$277.8 million in 2025, then slumped by 39.2% to -$386.7 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$386.7 million, -$277.8 million, and -$254.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison